Secukinumab in moderate-to-severe hidradenitis suppurativa (SUNSHINE and SUNRISE): week 16 and week 52 results of two identical, multicentre, randomised, placebo-controlled, double-blind phase 3 trials
Published 2023 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Secukinumab in moderate-to-severe hidradenitis suppurativa (SUNSHINE and SUNRISE): week 16 and week 52 results of two identical, multicentre, randomised, placebo-controlled, double-blind phase 3 trials
Authors
Keywords
-
Journal
LANCET
Volume -, Issue -, Pages -
Publisher
Elsevier BV
Online
2023-02-04
DOI
10.1016/s0140-6736(23)00022-3
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Long-term Safety of Secukinumab Over Five Years in Patients with Moderate-to-severe Plaque Psoriasis, Psoriatic Arthritis and Ankylosing Spondylitis: Update on Integrated Pooled Clinical Trial and Post-marketing Surveillance Data
- (2022) Alice B. Gottlieb et al. ACTA DERMATO-VENEREOLOGICA
- Candida Infection Associated with Anti-IL-17 Medication: A Systematic Analysis and Review of the Literature
- (2022) Mika Yamanaka-Takaichi et al. AMERICAN JOURNAL OF CLINICAL DERMATOLOGY
- IL‐17A is a pertinent therapeutic target for moderate to severe hidradenitis suppurativa: combined results from a pre‐clinical and Phase II proof‐of‐concept study
- (2022) Alexa B. Kimball et al. EXPERIMENTAL DERMATOLOGY
- Advances in biologic and small molecule therapies for hidradenitis suppurativa
- (2022) Stella X. Chen et al. EXPERT OPINION ON PHARMACOTHERAPY
- Efficacy and Safety of Bimekizumab in Moderate to Severe Hidradenitis Suppurativa
- (2021) Sophie Glatt et al. JAMA Dermatology
- Efficacy and Safety of Adalimumab in Conjunction With Surgery in Moderate to Severe Hidradenitis Suppurativa
- (2021) Falk G. Bechara et al. JAMA Surgery
- Drug Survival of Biologics in Patients With Hidradenitis Suppurativa
- (2021) Hans Christian Ring et al. JAMA Dermatology
- A Phase II Open-Label Study of Bermekimab in Patients with Hidradenitis Suppurativa Shows Resolution of Inflammatory Lesions and Pain
- (2020) Alice Gottlieb et al. JOURNAL OF INVESTIGATIVE DERMATOLOGY
- Effectiveness of secukinumab in Hidradenitis Suppurativa : an open study (20 cases)
- (2020) Z. Reguiaï et al. JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY
- Hidradenitis suppurativa
- (2020) Robert Sabat et al. Nature Reviews Disease Primers
- Delayed Diagnosis of Hidradenitis Suppurativa and Its Effect on Patients and Healthcare System
- (2020) Georgios Kokolakis et al. DERMATOLOGY
- High placebo rates in clinical trials: is the problem scoring systems or drug efficacy?
- (2020) Alexa B. Kimball JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY
- The epidemiology of hidradenitis suppurativa
- (2020) John R. Ingram BRITISH JOURNAL OF DERMATOLOGY
- North American Clinical Management Guidelines for Hidradenitis Suppurativa: a Publication from the United States and Canadian Hidradenitis Suppurativa Foundations. Part II: Topical, Intralesional, and Systemic medical Management
- (2019) A. Alikhan et al. JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY
- Open‐label, investigator‐initiated, single‐site exploratory trial evaluating secukinumab, an anti‐interleukin‐17A monoclonal antibody, for patients with moderate‐to‐severe hidradenitis suppurativa
- (2019) L. Prussick et al. BRITISH JOURNAL OF DERMATOLOGY
- Associations of cutaneous and extra‐cutaneous infections with Hidradenitis Suppurativa in US children and adults
- (2019) H. H. Lee et al. BRITISH JOURNAL OF DERMATOLOGY
- Determining the Optimal Dose of Infliximab for Treatment of Hidradenitis Suppurativa
- (2019) Ashley N. Oskardmay et al. JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY
- Model-Informed Drug Development Approach Supporting Approval of Adalimumab (HUMIRA) in Adolescent Patients with Hidradenitis Suppurativa: a Regulatory Perspective
- (2019) Youwei Bi et al. AAPS Journal
- Evaluating Patients’ Unmet Needs in Hidradenitis Suppurativa: results from the Global VOICE project
- (2019) Amit Garg et al. JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY
- Association of Hidradenitis Suppurativa With Inflammatory Bowel Disease
- (2019) Wei-Ti Chen et al. JAMA Dermatology
- Depression and Anxiety in Adults With Hidradenitis Suppurativa
- (2019) Myrela O. Machado et al. JAMA Dermatology
- A Comparison of International Management Guidelines for Hidradenitis Suppurativa
- (2019) Aleksi J. Hendricks et al. DERMATOLOGY
- Part I. Hidradenitis Suppurativa: Epidemiology, clinical presentation, and pathogenesis
- (2019) Samantha R. Goldburg et al. JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY
- Severe hidradenitis suppurativa responding to treatment with secukinumab: a case report
- (2018) L. Thorlacius et al. BRITISH JOURNAL OF DERMATOLOGY
- Profound consequences of hidradenitis suppurativa: a review
- (2018) Ł. Matusiak BRITISH JOURNAL OF DERMATOLOGY
- Increased Suicide Risk in Patients with Hidradenitis Suppurativa
- (2018) Linnea Thorlacius et al. JOURNAL OF INVESTIGATIVE DERMATOLOGY
- Increased interleukin (IL)-17 serum levels in patients with hidradenitis suppurativa: Implications for treatment with anti-IL-17 agents
- (2017) Łukasz Matusiak et al. JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY
- Two Phase 3 Trials of Adalimumab for Hidradenitis Suppurativa
- (2016) Alexa B. Kimball et al. NEW ENGLAND JOURNAL OF MEDICINE
- Dysregulated cytokine expression in lesional and nonlesional skin in hidradenitis suppurativa
- (2015) G. Kelly et al. BRITISH JOURNAL OF DERMATOLOGY
- Diagnostic delay in hidradenitis suppurativa is a global problem
- (2015) D.M. Saunte et al. BRITISH JOURNAL OF DERMATOLOGY
- Pathophysiology of hidradenitis suppurativa: An update
- (2015) Errol Prens et al. JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY
- European S1 guideline for the treatment of hidradenitis suppurativa/acne inversa
- (2015) C.C. Zouboulis et al. JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY
- Assessing the validity, responsiveness and meaningfulness of the Hidradenitis Suppurativa Clinical Response (HiSCR) as the clinical endpoint for hidradenitis suppurativa treatment
- (2014) A.B. Kimball et al. BRITISH JOURNAL OF DERMATOLOGY
- Hidradenitis suppurativa: a common and burdensome, yet under-recognised, inflammatory skin disease
- (2014) Deirdre Nathalie Dufour et al. POSTGRADUATE MEDICAL JOURNAL
- Painful Hidradenitis Suppurativa
- (2010) Howard S. Smith et al. CLINICAL JOURNAL OF PAIN
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationPublish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn More